Company

R Paul Schaudies, Ph.D., GenArraytion's President and Chief Executive Officer

Dr. Schaudies background includes positions in line management for a Fortune 300 company and program management for the US military.  Prior to founding GenArraytion, Dr. Schaudies managed the Biological and Chemical Defense Division at SAIC.  He is an internationally recognized expert in biotechnology and nanotechnology, and has served on ten National Research Council committees.  Dr. Schaudies was the science advisor to the Incident Commander and the EPA On-Scene Coordinator during the 2001 anthrax incident in Washington, DC.  He has served on numerous advisory committees for government agencies including DARPA and DOE and has been chairman of numerous technology conferences, including several Gordon Research Conferences.  Dr. Schaudies spent thirteen years as an active duty Army officer and retired as a Lieutenant Colonel from the USAR.  While on active duty, Dr. Schaudies  was the Program Manager for Biological and Chemical Defense Research, a Senior Researcher at the Walter Reed Army Institute for Research and the Chief of the General Support Laboratory in the Department of Clinical Investigation at Walter Reed Army Medical Center. Dr. Schaudies earned his Ph.D. in Biochemistry at the Temple School of Medicine and was a visiting scientist in the Laboratory of Cellular and Molecular Biology at the National Cancer Institute.  He received a bachelor's degree in Chemistry from Wake Forest.

Dr. Doreen Robinson, GenArraytion's Chief Operations Officer

Dr. Robinson has experience in business development, project and personnel management and strategic planning.  Prior to founding GenArraytion, Dr. Robinson was a member of SAIC's Biological and Chemical Defense Division where she played a key role in business development and delivery of strategic planning advice, program management services and technical support to more than a dozen US Government agencies.  She is well connected in the government contracting arena and in the growing mid-Atlantic biotechnology community through her entrepreneurial network and teaching at the University of Maryland University College Graduate School of Management and Technology. Dr. Robinson has a broad scientific background in molecular and cellular biology, pharmacology, biochemistry, immunology and microbiology.  She received a doctorate in Biochemical Pharmacology from the State University of New York at Buffalo and performed graduate research in the Laboratory of Molecular and Cellular Neurobiology at the National Institute of Neurological Disorders and Stroke.  She has an undergraduate degree in Microbiology from Cornell University.